Global Drug Facility Annual Report 2011 [.pdf] - Stop TB Partnership

More documents

Recommendations

Info

28 GLOBAL DRUG FACILITY Planning and supply chain management Good planning ensures that quality goods can be delivered to the right people at the right price and at the right time. In particular, planning ensures that there are no stock outs and patients are not prevented from taking the medication that they need. Simply put, if countries fail to plan, they can plan to fail. Figure 15 illustrates the supply chain management cycle, actors responsible and estimated time frames. Stock outs were experienced in 14 countries in 2011: Burundi, Cape Verde, Central African Republic, Eritrea, Ghana, Kenya, Madagascar, Malawi, Mali, Nigeria, Rwanda, Swaziland, Tanzania and Uzbekistan. Monitoring mission reports suggest that poor planning, late disbursement of funds by governments and donors and manufacturing delays all contributed to these stock outs. In 2011, Management Sciences for Health and GDF began collaboration on a project to implement an early warning stock out system that can detect stock out risk so that preventive action can be taken.
29 ANNUAL REPORT 2011 Review • Annual • Identify problems • Under / overstocking • Recommendations • MSH review 4–6 weeks (GDF/NTP) Monitoring Missions • Quantification • Procurement plan • Funding 1–2 years Initiation Stage (NTP) Analyse • Pre-shipment inspection • Batch testing • Freight forwarding • Clearance • Medical storage depot 6–10 weeks (GDF/NTP) Logistics Procurement Cycle Production (GDF/ Suppliers) Procurement (GDF) Plan • Retrospective analysis • Annual bidding for long-term agreements 2–3 months Do • Place purchase order on receipt of funded requisition • Manufacturing period, including ordering of APIs 10–12 weeks Figure 14 TB drug supply chain management cycle
Page 1 and 2: GLOBAL DRUG FACILITY ANNUAL REPORT
Page 3 and 4: Contents 02 | About the Global Drug
Page 5 and 6: 03 ANNUAL REPORT 2011 Message from
Page 7 and 8: 05 ANNUAL REPORT 2011 GDF was estab
Page 9 and 10: 07 ANNUAL REPORT 2011 Commodity exp
Page 11 and 12: 9 ANNUAL REPORT 2011 2010 GDF Grant
Page 13 and 14: 11 ANNUAL REPORT 2011 Historical an
Page 15 and 16: 13 ANNUAL REPORT 2011 80 70 60 Proc
Page 17 and 18: 15 ANNUAL REPORT 2011 2010 2011 Fre
Page 19 and 20: 17 ANNUAL REPORT 2011 There were ot
Page 21 and 22: 19 ANNUAL REPORT 2011 Diagnostics I
Page 23 and 24: 21 ANNUAL REPORT 2011 First-line dr
Page 25 and 26: 23 ANNUAL REPORT 2011 MDR-TB throug
Page 27 and 28: 25 ANNUAL REPORT 2011 Stockpile In
Page 29: 27 ANNUAL REPORT 2011 Key performan
Page 33 and 34: 31 ANNUAL REPORT 2011 Monitoring mi
Page 35 and 36: 33 ANNUAL REPORT 2011 Annex 2 Patie
Page 37 and 38: 35 ANNUAL REPORT 2011 Country 2011
Page 39 and 40: 37 ANNUAL REPORT 2011 Country Suppl
Page 41 and 42: 39 ANNUAL REPORT 2011 WHO Region Co
Page 43 and 44: 41 ANNUAL REPORT 2011 Annex 5 GeneX
Page 45 and 46: 43 ANNUAL REPORT 2011 Countries rev
Page 48: Stop TB Partnership www.stoptb.org

Global Drug Facility Annual Report 2011 [.pdf] - Stop TB Partnership

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?